| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189778 | Brachytherapy | 2013 | 8 Pages |
Abstract
HDR endoluminal brachytherapy is a well-tolerated treatment for superficial primary and recurrent EC in medically inoperable patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael R. Folkert, Gil'ad N. Cohen, Abraham J. Wu, Hans Gerdes, Mark A. Schattner, Arnold J. Markowitz, Emmy Ludwig, David H. Ilson, Manjit S. Bains, Michael J. Zelefsky, Karyn A. Goodman,